Update Gewerblicher Rechtsschutz und Kartellrecht

Zusammenhängende Inhalte

• 23.03.2023

  Eu­ro­pean Pa­tent Of­fice (EPO) dig­ging its heals in over the need for de­scrip­ti­on amend­ments, but how to do this re­mains a chal­len­ge

  As a complement to the 10th edition of the EPO "Case Law of the Boards of Appeal" (CLB), the EPO has published an Annual Review containing summaries of decisions from 2022. The review provides a thematic overview of selected decisions of the boards of...
• 22.03.2023

  Eu­ro­pean Pa­tent Of­fice (EPO) le­vel of dis­clo­sure re­qui­red for an­ti­bo­dies - first me­di­cal use

  As a complement to the 10th edition of the EPO "Case Law of the Boards of Appeal" (CLB), the EPO has published an Annual Review containing summaries of decisions from 2022. The review provides a thematic overview of selected decisions of the Boards of...
• 22.03.2023

  Is a pa­ti­ent in a cli­ni­cal tri­al con­side­red to be a mem­ber of the pu­blic in the con­text of no­vel­ty pri­or art?

  In T 0670/20, the question was whether the internal structure of medicinal tablets had been made available to the public by patients taking part in clinical trials involving administration of the tablets. The Appeal Board found that the patients participating...